Patent · US Active

Solid forms of 4-(2-fluoro-4-(1-methyl-1H-benzo[d]imidazol-5-yl)benzoyl)piperazin-1-yl)(1-hydroxycyclopropyl)methanone

US10793554B2 · kind B2 · utility

0Cited by

59References

23Claims

0Family size

Assignee

FORMA Therapeutics, Inc. · US

Inventors

George P. Luke · Clinton, US
Stephen Hubbs · Groton, US
Matthew W. Martin · Arlington, US
Robert Wenslow · Plainsboro, US
Yawei Shi · Beijing, CN
Jun Huang · San Diego, US

Key dates

Filing date	Oct 29, 2019
Grant date	Oct 6, 2020
Priority date	—
Expiry date	Oct 29, 2039

Classification

Technology area (CPC C)Chemistry; Metallurgy
CPC primaryC07B2200/13
WIPO fieldOrganic fine chemistry
WIPO sectorChemistry

Abstract

The present disclosure reports solid forms of (4-(2-fluoro-4-(1-methyl-1H- benzo[d]imidazol-5-yl)benzoyl)piperazin-1-yl)(1-hydroxycyclopropyl)methanone:

Source: USPTO / EPO open patent data. Objective bibliographic and citation counts.